Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.69 |
| ▸ | RAB9A | P51151 | 8/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL5919025 | 0.98 | NPC1 (0.67) | NPC1RAB9AALDH1A1EPHX2HDAC3 | |
| Hydrochloric Acid SCHEMBL28989899 | 0.98 | NPC1 (0.67) | NPC1RAB9AALDH1A1EPHX2HDAC3 | |
| Phosphoric Acid SCHEMBL7202878 | 0.92 | RAB9A (0.66) | NPC1RAB9AEPHX2 | |
| Pyrazine SCHEMBL9234910 | 0.91 | NPC1 (0.59) | NPC1RAB9AEPHX2KMT2ATDP1 | |
| SCHEMBL1990363 | 0.87 | NPC1 (0.69) | NPC1RAB9AALDH1A1EPHX2HDAC3 | |
| SCHEMBL693305 | 0.85 | NPC1 (0.67) | NPC1RAB9AALDH1A1EPHX2HDAC3 | |
| SCHEMBL873416 | 0.83 | NPC1 (0.65) | NPC1RAB9AALDH1A1EPHX2HDAC3 | |
| SCHEMBL14852000 | 0.83 | NPC1 (0.65) | NPC1RAB9AALDH1A1EPHX2HDAC3 | |
| SCHEMBL680273 | 0.83 | NPC1 (0.65) | NPC1RAB9AALDH1A1EPHX2 | |
| SCHEMBL16195828 | 0.83 | RAB9A (0.51) | NPC1RAB9AHDAC3NCOR2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240409535-A1 | SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE | GENENTECH, INC. (US) | 2024-12-12 | — | — | US | claimed |
| US-20240024489-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | INSTITUT PASTEUR (FR) | 2024-01-25 | — | — | US | claimed |
| EP-4247828-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | Institut Pasteur (FR) | 2023-09-27 | — | — | EP | claimed |
| CN-116601163-A | Protected disaccharides, methods for their preparation, their use in the synthesis of zwitterionic oligosaccharides and conjugates thereof | 巴斯德研究所 | 2023-08-15 | — | — | CN | claimed |
| CN-111655791-B | Pest and ice phobic compositions with fluid additives | HRL实验室有限责任公司 | 2022-11-04 | — | — | CN | claimed |
| WO-2022106703-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | INSTITUT PASTEUR (FR) | 2022-05-27 | — | — | WO | claimed |
| US-11084794-B2 | Controlled cyclization of peptoids to form chiral diketopiperazines | TRIAD NATIONAL SECURITY, LLC (US) | 2021-08-10 | — | — | US | claimed |
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | HRL LABORATORIES, LLC (US) | 2021-07-27 | — | — | US | claimed |
| EP-3746509-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL Laboratories, LLC (US) | 2020-12-09 | — | — | EP | claimed |
| CN-111655791-A | Pest and ice phobic compositions with fluid additives | HRL实验室有限责任公司 | 2020-09-11 | — | — | CN | claimed |
| WO-2016043661-A1 | MODIFIED PEPTIDE NUCLEIC ACIDS AND THEIR USE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-03-24 | — | — | WO | claimed |
| WO-2015092739-A1 | PROCESS FOR PREPARATION OF ALOGLIPTIN | Mylan Laboratories Ltd. (IN) | 2015-06-25 | — | — | WO | claimed |
| CN-101454333-B | Lactosamine derivatives | GLYCOM AS | 2013-08-28 | — | — | CN | claimed |
| US-8207328-B2 | Lactosamine derivatives | GLYCOM APS (DK) | 2012-06-26 | — | — | US | claimed |
| EP-1996602-B8 | NOVEL LACTOSAMINE DERIVATIVES | GLYCOM AS (DK) | 2012-03-14 | — | — | EP | claimed |
| EP-1996602-B1 | NOVEL LACTOSAMINE DERIVATIVES | GLYCOM APS (DK) | 2011-02-16 | — | — | EP | claimed |
| US-20090234111-A1 | Novel Lactosamine Derivatives | GLYCOM APS (DK) | 2009-09-17 | — | — | US | claimed |
| CN-101454333-A | Novel lactosamine derivatives | GLYCOM APS (DK) | 2009-06-10 | — | — | CN | claimed |
| EP-1996602-A1 | NOVEL LACTOSAMINE DERIVATIVES | Glycom APS (DK) | 2008-12-03 | — | — | EP | claimed |
| WO-2007104311-A1 | NOVEL LACTOSAMINE DERIVATIVES | GLYCOM APS (DK) | 2007-09-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024489-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | SI, DAD1, FUT5 | NPC1 3429/4885RAB9A 2007/4885ALDH1A1 3593/4885 |
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | FUS, IGF2BP1, IGF2BP3 | NPC1 1203/4885RAB9A 3929/4885ALDH1A1 3660/4885 |
| US-20090234111-A1 | Novel Lactosamine Derivatives | B3GNT2, FUT6, FUT5 | NPC1 3320/4885RAB9A 2753/4885ALDH1A1 1300/4885 |
| US-11084794-B2 | Controlled cyclization of peptoids to form chiral diketopiperazines | NPPA, NPEPPS, RRP15 | NPC1 1136/4885RAB9A 3975/4885ALDH1A1 4849/4885 |
| US-20240409535-A1 | SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE | TP53, DPYD, FLI1 | NPC1 1976/4885RAB9A 1660/4885ALDH1A1 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.